The difference in results between our study and other different study centers also suggested that for ETV6/RUNX1-positive children with B-ALL, the risk stratification criteria and choice of treatment regimen can significantly affect the prognosis of such children and is a key factor to further improve the prognosis with this subtype (38). This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.